JPRN-jRCTs061180079进行中（未招募）2 期
Japan colorectal tumor prevention study: randomized controlled trial of curcumin - J-CAP-C
Takayama Tetsuji0 个研究点目标入组 600 人开始时间: 2019年3月20日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 30age old 至 <= 75age old（—）
- 性别
- All
入选标准
- •Candidate patients have to meet all the following inclusion criteria to participate in the study.
- •# Patients with at least one colorectal tumor (intramucosal cancer and adenoma) as confirmed by histological diagnosis, all of which have been removed endoscopically (at any time)
- •# Patients with known history of all endoscopic treatments (including histological diagnosis) of colorectal tumors
- •# Patients who have undergone total colonoscopy at least twice
- •# Patients with clean colon as confirmed by total colonoscopy within 3 months before the study
排除标准
- •# Patients with a medical history of submucosal or deeper colorectal cancer.
- •# Patients currently taking antithrombotics such as Bayaspirin, Bufferin, Panaldine, Warfarin, Persantin and NOAC.
- •# Patients who have undergone colorectal resection (those who have undergone appendectomy are allowed to participate in the study).
- •# Patients with familial colorectal adenoma.
- •# Patients with any existing cancer at the time of participation in the study.
- •# Patients with known allergy to curcumin.
- •# Patients currently taking anticancer drugs.
- •# Women who are or may be pregnant during the study period.
- •# Patients currently taking NSAIDs at least 3 times weekly, for example, as a analgesic.
- •# Patients with ulcerative colitis or Crohn's disease
- •# Patients with bleeding tendency or platelet count less than 70,000.
- •# Patient taking turmeric as a supplement.
- •# Patient deemed inappropriate by a doctor
研究者
相似试验
招募中
2 期
Japan colorectal tumor prevention study: randomized controlled trial of curcumicolorectal tumorJPRN-UMIN000018817Management Committee600
已完成
3 期
Japan colorectal tumor prevention study: clinical trial by low-dose aspiriPatients with colorectal tumor (adenoma, carcinoma in situ)JPRN-UMIN000018734Kyoto Prefectural University of Medicine7,000
进行中（未招募）
3 期
Japan colorectal tumor prevention study: clinical trial by low-dose aspirin (J-CAPP Study II)Patients with colorectal tumor (adenoma, carcinoma in situ)JPRN-jRCTs051180161Ishikawa Hideki4,500
已完成
3 期
Japan colorectal tumor prevention study: randomized controlled trial by low-dose aspiricolorectal tumorJPRN-UMIN000000697Basic and clinical researches on the development of chemopreventive drugs700
已完成
1 期
Intervention trial for colorectal cancer prevention by endoscopic polypectomy in patients with familial adenomatous polyposisfamilial adenomatous polyposisJPRN-UMIN000009365AMED222